Price history
¥3,730Latest+103.2%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 17
PER
13.97How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
0.97How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
6.9%Earning power. A figure above 10% is generally considered good.Equity ratio
34.6%The proportion of assets funded by money that does not have to be repaid.Operating margin
1.1%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
3.3%The average annual growth in sales over the past three years.Forward P/E
16.37Forward P/E based on estimated earnings for the next fiscal year.PSR
0.14The number of times sales are valued. Used to assess companies that are not profitable.What to watch next
Plan to establish the new Shin-Tosu TMS Center (total investment: ¥2,173 million; construction start: March 2024; scheduled completion: March 2027)
Around March 2027 (scheduled completion)Impact HighLikelihood Medium
Improved operating efficiency as the introduction of logistics automation, including automated warehouses, transport robots and WMS, progresses
Impact MediumLikelihood Medium
An increase in facilities under SPD contracts, market adoption of web-based materials management systems such as MeRCare-y, and monetization of procurement management consulting
From 2026 onward, in stagesImpact MediumLikelihood Medium
Progress in the clinical evaluation of the Breast Scan ultrasound diagnostic imaging system, providing clues as to when it may become a commercial product
Impact HighLikelihood Low
What to watch next
Who owns itTop holders total 68.4%
Listed holders 68.4%Everyone else 31.6%
Yamashita Naoto (山下 尚登)24.44%
Yamashita Healthcare Holdings Employee Stock Ownership Plan10.33%
SBI SECURITIES CO., LTD.8.54%
Yamashita Hirotaka (山下 弘高)5.11%
Triple Four Investment Partnership4.97%
上田八木短資株式会社4.72%
Yamashita Koichi (山下 耕一)3.69%
株式会社十八親和銀行2.75%
2 other listed holders3.90%
| Holder | Ownership (%) |
|---|---|
| Yamashita Naoto (山下 尚登) | 24.44 |
| Yamashita Healthcare Holdings Employee Stock Ownership Plan | 10.33 |
| SBI SECURITIES CO., LTD. | 8.54 |
| Yamashita Hirotaka (山下 弘高) | 5.11 |
| Triple Four Investment Partnership | 4.97 |
| 上田八木短資株式会社 | 4.72 |
| Yamashita Koichi (山下 耕一) | 3.69 |
| 株式会社十八親和銀行 | 2.75 |
| 2 other listed holders | 3.90 |
This company's documents
Filings
Timely disclosures
- 2026-09-30Summary of Financial Results for the First Quarter of the Fiscal Year Ending May 2027 [Japanese GAAP] (Consolidated)
- 2026-09-17Our ESG Initiatives: Results and Targets Based on Our ESG Policy
- 2026-08-03Other Matters Subject to Electronic Provision for the 9th Ordinary General Meeting of Shareholders (Matters Omitted from the Documents Delivered)
- 2026-08-03Notice of Convocation of the 9th Annual General Meeting of Shareholders
- 2026-07-22Notice Regarding the Board of Directors’ Opinion on the Shareholder Proposal at the 9th Annual General Meeting of Shareholders
- 2026-07-13Notice Regarding Differences Between Full-Year Consolidated Earnings Forecasts and Actual Results
- 2026-07-13Notice Regarding Dividend of Surplus (Commemorative Dividend)
- 2026-07-13Summary of Financial Results for the Fiscal Year Ended May 2026 [Japanese GAAP] (Consolidated)
42 more
- 2026-06-16Overview of the Results of the Evaluation of the Board of Directors’ Effectiveness
- 2026-05-25Notice Regarding Completion of Payment for the Disposal of Treasury Shares as Restricted Stock to the Employee Shareholding Association and Partial Forfeiture
- 2026-04-14Notice Regarding the Disposal of Treasury Shares as Restricted Stock to the Employee Stock Ownership Plan
- 2026-03-31Summary of Financial Results for the Third Quarter of the Fiscal Year Ending May 2026 [Japanese GAAP] (Consolidated)
- 2026-01-14Financial Results Summary for the second quarter of the fiscal year ending May 2026 [Japanese GAAP] (Consolidated)
- 2025-10-30Notice regarding the results and completion of the acquisition of treasury shares through an off-auction purchase
- 2025-10-29Notice Regarding the Acquisition of Treasury Shares and the Purchase of Treasury Shares through an Off-Auction Treasury Share Purchase Transaction
- 2025-09-30Summary of Financial Results for the First Quarter of the Fiscal Year Ending May 2026 [Japanese GAAP] (Consolidated)
- 2025-07-11Notice Regarding Dividend from Retained Earnings
- 2025-07-11Summary of Financial Results for the Fiscal Year Ended May 2025 [Japanese GAAP] (Consolidated)
- 2025-07-01Notice Regarding Completion of Payment for the Disposal of Treasury Shares as Restricted Stock to the Employee Shareholding Association and Partial Forfeiture
- 2025-03-31Financial Results Summary for the third quarter of the fiscal year ending May 2025 [Japanese GAAP] (Consolidated)
- 2025-01-14Financial Results Summary for the second quarter (interim period) of the fiscal year ending May 2025 [Japanese GAAP] (Consolidated)
- 2024-11-18Notice Regarding the Disposal of Treasury Shares as Restricted Stock to the Employee Stock Ownership Plan
- 2024-09-30Summary of Financial Results for the First Quarter of the Fiscal Year Ended May 2025 [Japanese GAAP] (Consolidated)
- 2024-08-26Notice Regarding the Status of Share Repurchases and Completion of the Repurchase
- 2024-08-05Notice Regarding the Status of Share Repurchases (Interim Progress)
- 2024-07-12Notice regarding a change in the impairment loss recognized in connection with the opening of a new logistics center and the difference between the full-year consolidated earnings forecast and actual results
- 2024-07-12Notice Regarding Dividend from Retained Earnings
- 2024-07-12Summary of Financial Results for the Fiscal Year Ended May 2024 [Japanese GAAP] (Consolidated)
- 2024-07-05Notice Regarding the Status of Share Repurchases (Interim Progress)
- 2024-06-05Notice Regarding the Status of Share Repurchases (Interim Progress)
- 2024-05-30Notice regarding the acquisition of shares in Microsonic Co., Ltd. and its conversion into a subsidiary
- 2024-05-21Notice Regarding a Change in Major Shareholders
- 2024-05-07Notice Regarding the Status of Share Repurchases (Interim Progress)
- 2024-03-29Notice regarding the recognition of an impairment loss in connection with the opening of a new logistics center
- 2024-03-29Notice Regarding Revisions to Full-Year Consolidated Earnings Forecast
- 2024-03-29Summary of Financial Results for the Third Quarter of the Fiscal Year Ended May 2024 [Japanese GAAP] (Consolidated)
- 2024-01-12Summary of Financial Results for the Second Quarter of the Fiscal Year Ended May 2024 [Japanese GAAP] (Consolidated)
- 2023-09-29Financial Results Summary for the first quarter of the fiscal year ending May 2024 [Japanese GAAP] (Consolidated)
- 2023-07-14Notice Regarding Dividend from Retained Earnings
- 2023-07-14Financial Results Summary for the fiscal year ended May 2023 [Japanese GAAP] (Consolidated)
- 2023-03-31Notice Regarding Revisions to Full-Year Consolidated Earnings Forecast
- 2023-03-31Financial Results Summary for the third quarter of the fiscal year ended May 2023 [Japanese GAAP] (Consolidated)
- 2023-01-06Notice regarding the risk of collection failure or delay in collecting receivables and the recognition of an extraordinary loss
- 2023-01-06Financial Results Summary for the second quarter of the fiscal year ended May 2023 [Japanese GAAP] (Consolidated)
- 2022-11-01Notice Concerning the Risk of Collection Failure or Delay
- 2022-09-30Financial Results Summary for the first quarter of the fiscal year ended May 2023 [Japanese GAAP] (Consolidated)
- 2022-07-14Notice Regarding Dividend from Retained Earnings
- 2022-07-14Financial Results Summary for the fiscal year ended May 2022 [Japanese GAAP] (Consolidated)
- 2022-03-31Notice Regarding Revisions to Earnings Forecasts and Dividend Forecast
- 2022-03-31Financial Results Summary for the third quarter of the fiscal year ending May 2022 [Japanese GAAP] (Consolidated)
Threads
- 2026-09-30Expanding the SPD Business by Leveraging the Logistics Infrastructure
- 2026-09-30Improving Profitability through Greater Price Competitiveness and Cost Reduction
- 2026-09-30First-Year Third-Quarter Sales and Profit Performance
- 2026-09-30Strengthening the Business Base through Solution-Based Sales and Healthcare Management Consulting
- 2026-09-30Expanding Distribution Channels for the Orthopedic Implant アレクサネイル
- 2026-09-30Uncertainty About the Outlook Due to Trade Issues, Overseas Economic Uncertainty and Financial Market Volatility
- 2026-09-30Revenue Performance of the Medical Mall Business
- 2026-09-30Promoting DX Across All Business Processes
70 more
- 2026-09-30Restricted Stock Incentives for Employees
- 2026-09-30Neutrality and Conflict-of-Interest Risks Associated with a Proposed Capital and Business Alliance and Shareholder Proposal by a Specific Shareholder
- 2026-09-18Financial Targets under the New Medium-Term Management Plan for the Fiscal Years Ending May 2025 to May 2027
- 2026-09-17Quality, Safety and Legal Compliance as a Healthcare Company
- 2026-09-17Developing Human Resources and Energizing the Organization through Enhanced Training Programs
- 2026-09-17Female Representation of at Least 30% among New Graduate Hires and Promoting Diversity
- 2026-09-17Strengthening the Management Platform from an ESG and SDG Perspective
- 2026-09-17Reducing CO2 Emissions and Addressing Carbon Neutrality
- 2026-08-25Impact of Medical Fee Revisions and Lower Medical Material Prices
- 2026-08-25Changes in Healthcare and Long-Term Care Delivery Systems Toward 2025
- 2026-08-25Developing Growth in Healthcare IT and Expanding Electronic Medical Record Adoption
- 2026-08-25Risk of Impairment of Fixed Assets Due to Deteriorating Business Earnings and Cash Flow
- 2026-08-25Customer Credit Risk Associated with Trade Receivables
- 2026-08-25Group Oversight and Internal Controls through the Audit and Supervisory Committee and Internal Audits
- 2026-08-25Stable and Consistent Dividends Based on a 30% Consolidated Payout Ratio
- 2026-08-25Decline in Operating Cash Flow Due to Increased Working Capital
- 2026-08-25Nomination and Compensation Committee and Performance-Linked Compensation
- 2026-08-25Risk of Inadequate Revenue Recognition Controls for Direct-Shipment Medical Device Transactions
- 2026-08-25Development of the BreastScan Ultrasound Diagnostic System
- 2026-08-25Strengthening Brand Value and the Customer Base on the Occasion of the Company's 100th Anniversary
- 2026-08-25Transition from a Defined Benefit Pension Plan to a Defined Contribution Pension Plan
- 2026-08-25Preparing to Adopt the New Lease Accounting Standard in the Fiscal Year Ending May 2028
- 2026-08-25Review of Board Composition Including a Shareholder Proposal
- 2026-08-03Corporate Value Enhancement Target Including a PBR of at Least 1x
- 2026-08-03Multiply Vision 2030 and Sustainable Management
- 2026-07-22Achieving Medium-Term ROE of at Least 10%
- 2026-07-22Flexible capital policy through share repurchases
- 2026-07-13Information security risk from cyberattacks and other threats
- 2026-03-31Deterioration in the Business Environment Due to Higher Energy and Raw Material Prices
- 2026-01-14Transition to a Holding Company Structure and Strengthening Group Collaboration and Synergies
- 2026-01-14Expanding the Group and Improving Management Efficiency through Capital Alliances
- 2026-01-14Group Business Composition Centered on Medical Device Sales
- 2026-01-14Change in Independent Auditor
- 2025-01-14Pressure on Profitability from Higher Freight and Lease Costs
- 2024-08-27Suspension of Offices and Logistics Operations and Supply Delays Due to COVID-19 Infections
- 2024-08-27Risk to Human Resources from a Declining Workforce and an Active Job-Change Market
- 2024-08-27Risk of Business and Sales Restrictions Due to Environmental Regulations
- 2024-01-12Concern over the Impact of COVID-19 on Domestic and Overseas Economies
- 2023-08-25Promoting Health Management
- 2023-08-25Creating New Revenue Sources Based on Existing Businesses
- 2023-08-25Expansion of new products, including injection dispensing and audit support systems
- 2023-08-25Financial Targets for the Fiscal Year Ending May 2024 under the New Medium-Term Management Plan
- 2023-08-25Business Continuity Planning for Natural Disasters
- 2022-10-14Medical Device Delivery Delays Due to the Global Semiconductor Shortage
- 2022-04-14Application of the Accounting Standard for Revenue Recognition for the Fiscal Year Ending May 2022
- 2021-10-15Intensifying Competition and Pricing Pressure From New Entrants and Industry Consolidation
- 2021-08-27Accelerating Growth and Enhancing Corporate Value by Leveraging Economies of Scale
- 2021-08-27Concentration of logistics hubs and disruption of logistics operations caused by disasters
- 2021-08-27Risk of Failing to Meet Medical Device Laws and Licensing Requirements
- 2021-08-27Risk of Violating the Fair Competition Code for the Medical Device Industry
- 2021-08-27Risk of Damages Claims and Suspended Transactions Due to Violations of the Act on the Protection of Personal Information
- 2021-08-27Risk of Failing to Expand Distribution Channels for In-House-Developed Implants and Risk of Product Defects
- 2021-08-27Risk of Medical Accidents and Litigation Arising from Product Defects or Improper Installation
- 2021-08-27Risk of Post-M&A Integration Burdens, Failure to Achieve Synergies and Goodwill Impairment
- 2021-08-27Risk of Investment Securities Valuation Losses Due to Falling Share Prices or Weak Performance at Investee Companies
- 2021-08-27Creating Group Value and Contributing to Local Communities and Society
- 2021-08-27Achievement of Key Performance Targets under the Medium-Term Management Plan
- 2020-10-15Expanding the Business Scope by Addressing the Home Healthcare and Long-Term Care Markets
- 2020-10-15Ensuring Flexibility in Capital Policy Through a Reduction in Capital Reserves
- 2020-08-28Launching the EPARK Business Through a Capital and Business Alliance
- 2020-08-28Enhancing Product Value and Proposal Capabilities by Strengthening Relationships with Suppliers and Business Partners
- 2020-08-28Interest-rate risk from floating-rate borrowings
- 2020-08-28Verifying the Rationale for Strategic Shareholdings and Reducing Holdings
- 2020-08-28Preventing Infection and Maintaining Supplies Through the COVID-19 Response Headquarters
- 2019-08-28Establishment of a pure holding company through a sole-share transfer
- 2019-08-28Promoting the Adoption of an Injectable Drug and Medical Supply Identification System
- 2019-08-28Converting Surgical Instruments to Single Use in Cooperation with a Taiwanese Manufacturer
- 2019-08-28Promoting Traffic Safety across the Group
- 2018-08-28Expanding Sales Channels in Dialysis Through the Integration of Toms Into the Group
- 2018-08-28Delays in Progress at a U.S. Emerging Medical Device Manufacturer and an Investment Valuation Loss